Overall, these results indicate that the downregulation of the innate immune response observed in NOKs+HPV16, particularly U-ISGF3 controlled genes, is representative of innate immune response downregulation in HPV positive head and neck cancers. This evidence concerns the gene IRF9 and head and neck cancer.